Javascript must be enabled to continue!
Circular RNAs in the tumour microenvironment
View through CrossRef
AbstractBackgroundCircular RNAs (circRNAs) are a new class of endogenous non-coding RNAs (ncRNAs) widely expressed in eukaryotic cells. Mounting evidence has highlighted circRNAs as critical regulators of various tumours. More importantly, circRNAs have been revealed to recruit and reprogram key components involved in the tumour microenvironment (TME), and mediate various signaling pathways, thus affecting tumourigenesis, angiogenesis, immune response, and metastatic progression.Main body of the abstractIn this review, we briefly introduce the biogenesis, characteristics and classification of circRNAs, and describe various mechanistic models of circRNAs. Further, we provide the first systematic overview of the interplay between circRNAs and cellular/non-cellular counterparts of the TME and highlight the potential of circRNAs as prospective biomarkers or targets in cancer clinics. Finally, we discuss the biological mechanisms through which the circRNAs drive development of resistance, revealing the mystery of circRNAs in drug resistance of tumours.Short conclusionDeep understanding the emerging role of circRNAs and their involvements in the TME may provide potential biomarkers and therapeutic targets for cancer patients. The combined targeting of circRNAs and co-activated components in the TME may achieve higher therapeutic efficiency and become a new mode of tumour therapy in the future.
Springer Science and Business Media LLC
Title: Circular RNAs in the tumour microenvironment
Description:
AbstractBackgroundCircular RNAs (circRNAs) are a new class of endogenous non-coding RNAs (ncRNAs) widely expressed in eukaryotic cells.
Mounting evidence has highlighted circRNAs as critical regulators of various tumours.
More importantly, circRNAs have been revealed to recruit and reprogram key components involved in the tumour microenvironment (TME), and mediate various signaling pathways, thus affecting tumourigenesis, angiogenesis, immune response, and metastatic progression.
Main body of the abstractIn this review, we briefly introduce the biogenesis, characteristics and classification of circRNAs, and describe various mechanistic models of circRNAs.
Further, we provide the first systematic overview of the interplay between circRNAs and cellular/non-cellular counterparts of the TME and highlight the potential of circRNAs as prospective biomarkers or targets in cancer clinics.
Finally, we discuss the biological mechanisms through which the circRNAs drive development of resistance, revealing the mystery of circRNAs in drug resistance of tumours.
Short conclusionDeep understanding the emerging role of circRNAs and their involvements in the TME may provide potential biomarkers and therapeutic targets for cancer patients.
The combined targeting of circRNAs and co-activated components in the TME may achieve higher therapeutic efficiency and become a new mode of tumour therapy in the future.
Related Results
Tumour Immunology
Tumour Immunology
Abstract
Tumour immunology is central to our understanding of the mechanisms of both tumour rejection and tumour progression. Vir...
Circular RNAs may embed pieces of real-world sensory information into an episodic memory
Circular RNAs may embed pieces of real-world sensory information into an episodic memory
Abstract
For a generation, neuroscience has searched for a molecule that stores our memories across time. This search has focused on proteomic me...
Tumour angiogenesis: vascular growth and survival
Tumour angiogenesis: vascular growth and survival
Angiogenesis starts at the edge of a malignant epithelial tumour concurrently with tumour cell invasion and stromatogenesis, i.e. the formation of specific connective tissue stroma...
Enhancing oncolytic virotherapy by exosome-mediated microRNA reprograming of the tumour microenvironment
Enhancing oncolytic virotherapy by exosome-mediated microRNA reprograming of the tumour microenvironment
Abstract
Background
There has been limited success of cancer immunotherapies in the treatment of ovarian cancer (OvCa) to date,...
TRIB1 regulates tumour growth via controlling tumour-associated macrophage phenotypes and is associated with breast cancer survival and treatment response
TRIB1 regulates tumour growth via controlling tumour-associated macrophage phenotypes and is associated with breast cancer survival and treatment response
SummaryMolecular mechanisms that regulate tumour-associated macrophage (TAM) phenotype and function are incompletely understood. Here, we show that the pseudokinase TRIB1 is highly...
A genome-wide circular RNA transcriptome in Rat
A genome-wide circular RNA transcriptome in Rat
Abstract
Background
Circular RNAs are a novel class of non-coding RNAs that backsplice from 5’ donor site and 3’ acceptor site ...
Harnessing iNKT cells to improve in situ vaccination for cancer therapy
Harnessing iNKT cells to improve in situ vaccination for cancer therapy
<p>Toll-like receptor (TLR) agonism in combination with the activation of type I NKT (iNKT) cells through systemic administration of their respective agonists has been shown ...
Methodological architectonics of inclusive circular economy for eco-security of society under pandemic
Methodological architectonics of inclusive circular economy for eco-security of society under pandemic
The transition from a linear to a circular economy is determined by the change in the positioning of global risks from year to year, which determines the vectors of such changes. T...

